CYP27A1 and type 2 diabetes mellitus: CYP27A1 has the potential to act both as susceptibility marker in T2D and CVD development and as a key event in the chain of events connecting obesity to T2D and CVD development, representing a new possible target in personalized preventive medicine of chronic degenerative diseases.